The Hidden Math of Litigation Finance: Why IRR Headlines Don't Tell the Full Story
- 1 day ago
- 5 min read
Updated: 9 hours ago
Nearly $15 billion in global litigation funding was deployed in 2023, yet a growing number of sophisticated investors are quietly reassessing how much of that capital was priced for the risks it actually carried. The headline numbers have always looked compelling. The reality, for those willing to look closely, is considerably more complex.

When the Numbers Look Simple But Aren't
Consider a straightforward scenario: a funder advances $10 million into a single case, targeting $12.5 million over three years. The implied IRR lands around 36%. Deploy that same capital across a diversified portfolio of cases with similar profiles, and the headline return looks just as attractive.
The math is clean. The problem is that it rests on two variables holding simultaneously: a successful legal outcome and a reasonable timeline to payment.
When either assumption slips, the impact compounds quickly. A single adverse ruling can eliminate returns entirely. A modest extension in case duration, even one that seems inconsequential, quietly erodes IRR in ways that don't appear in the original underwriting model. In mass tort portfolios specifically, where capital is spread across dozens of cases, each carrying its own outcome and timeline dependency, these risks don't simply add, they multiply.
The Systemic Risk Layer Most Investors Overlook
Duration Risk as a Silent Return Killer
Recent history has made this dynamic impossible to ignore. Landmark matters including Payment Card, Hernia Mesh, and Blue Cross/Blue Shield have extended well beyond their initial projections, in some cases stretching over a decade. For investors who modeled three-to-five-year hold periods, this isn't an inconvenience. It's a fundamental repricing of the asset.
As timelines stretch, the risks that once seemed theoretical begin to materialize. Credit facilities supporting law firms can come under pressure. Positions grow larger and more prolonged than originally underwritten. At a certain threshold, the funder faces an uncomfortable choice: continue extending capital to preserve the position, or reduce exposure and risk impairing the firm's ability to carry cases through to resolution.
Counterparty Risk at the Law Firm Level
This introduces a layer of systemic risk that rarely appears in investor presentations: the financial stability of the law firms themselves. Litigation finance has historically been underwritten on the merits of the case. But as duration extends and credit conditions tighten, the operational health of the firm becomes a material variable. A firm under liquidity pressure may not be positioned to optimize settlement outcomes, regardless of the underlying legal merit.
"What sophisticated investors are beginning to recognize is that pre-settlement/judgment litigation finance isn't a single risk, it's a stack of interdependent risks. Outcome, duration, and counterparty risk can all move against you at once, and the IRR model rarely prices that adequately," said Roni Dersovitz, Founder of Tower 3 Investments.
Rethinking the Entry Point in Litigation Funding
Why Post-Settlement/Judgment Changes the Risk Calculus
Post-settlement/judgment litigation finance represents a distinct segment within the broader alternative investment landscape, and one that is frequently misunderstood as simply a lower-return version of pre-settlement/judgment funding.
The structural and risk difference is more fundamental than that. By entering after a matter has resolved, capital is no longer exposed to binary outcome risk. The legal question has been answered. Underwriting can focus on duration, process, and the mechanics of disbursement, rather than the inherent uncertainty of litigation itself.
This shift doesn't eliminate risk. It redefines it. Hold periods become more predictable. Underwriting assumptions are grounded in documentation and established process rather than litigation probability. And the compounding of outcome and duration risk, the central challenge in pre-settlement/judgment portfolios, is largely removed from the equation.
Asset-Based Lending Principles Applied to Legal Receivables
Post-settlement and judgment receivables function more like asset-based lending than traditional litigation funding. The underlying asset, a resolved claim or judgment, exists. The work is in understanding the disbursement pipeline, the seniority of the position, and the expected timeline to payment. For institutional investors familiar with structured credit, the framework is more familiar than the litigation finance label might suggest.
Where Distressed Opportunities are Beginning to Emerge
The maturation of pre-settlement/judgment portfolios is creating a secondary dynamic that deserves attention from discerning investors. As large-scale portfolios age and capital remains tied up longer than originally projected, distressed assets are beginning to surface.
Portions of seasoned portfolios are trading at discounts, driven by liquidity pressures at the fund level, structural inefficiencies in portfolio construction, or simply the realities of capital that has been deployed longer than modeled. For sophisticated investors who can navigate the opacity of these positions, the opportunity to generate meaningful alpha exists, not by assuming additional litigation risk, but by acquiring positions from sellers who need liquidity more than they need to optimize exit pricing.
This is not a mainstream market. The information asymmetry is real, and the due diligence requirements are significant. But for investors with the analytical infrastructure to evaluate these positions, the inefficiency itself becomes the return driver.
A More Disciplined Approach to Litigation Finance
The growth of litigation funding as an alternative investment class has created a wide spectrum of risk and return profiles operating under a single label. Institutional investors who treat all litigation finance exposure as equivalent are likely to be surprised, in both directions.
The most compelling opportunities in the current environment share a common characteristic: they are priced against clearly defined risks rather than optimistic assumptions about outcomes and timelines that may or may not hold.
Post-settlement/judgment strategies and distressed portfolio acquisitions both reflect this discipline. Neither eliminates risk. Both allow for more transparent underwriting and more honest return expectations.
At Tower 3 Investments, our focus on post-settlement and judgment receivables reflects a deliberate choice to enter the litigation lifecycle at a point where the key variables are far more manageable. Shorter expected hold periods, more targeted underwriting, and the absence of binary outcome risk allow us to deliver consistent performance without embedding the structural risks that characterize much of the pre-settlement/judgment market.
The Bottom Line for Institutional Investors
Litigation finance has earned its place in the alternative investment conversation. The asset class offers genuine diversification, low correlation to traditional markets, and return potential that is difficult to replicate elsewhere.
But the math matters. IRR projections built on optimistic outcome assumptions and disciplined timelines can look almost identical to projections built on realistic analysis and conservative underwriting. The difference only becomes visible when the assumptions are stress-tested, or when the portfolio ages past its projected duration.
For institutional investors evaluating exposure to litigation funding, the right questions aren't only about expected returns. They're about which risks are being assumed, how those risks interact with each other, and whether the entry point into the asset class is aligned with the actual risk tolerance of the portfolio.
The opportunity in litigation finance is real. The discipline required to access it responsibly is what separates durable strategies from ones that look compelling until they don't.
About Tower 3 Investments
Tower 3 Investments delivers consistent returns through post-settlement and post-judgment litigation investments, serving institutional investors and sophisticated allocators seeking uncorrelated, asset-based lending alternatives.
Ready to explore post-settlement/judgment litigation finance opportunities? Contact Tower 3 Investments to learn how our specialized approach to funding settled or post-judgment cases can enhance your alternative investment portfolio.
Roni Dersovitz is the founder of Tower 3 Investments, LLC, a firm offering investment opportunities in Post-Settlement/Judgment Litigation Funding. Mr. Dersovitz has 14 years of experience as a practicing personal injury attorney and has managed portfolios of litigation based receivables since 1998. To learn more about access to differentiated returns through litigation finance, visit www.Tower3Investments.com or contact us at info@Tower3Investments.com.







